Exogenous nitric oxide can control SIRS and downregulate NFkappaB. [electronic resource]
Producer: 20050412Description: 52-8 p. digitalISSN:- 0022-4804
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- immunology
- Biocompatible Materials -- adverse effects
- Biomarkers
- Blood Vessel Prosthesis Implantation -- adverse effects
- Down-Regulation
- Intercellular Adhesion Molecule-1 -- immunology
- Male
- Models, Animal
- NF-kappa B -- immunology
- Nitric Oxide -- immunology
- Polyethylene Terephthalates -- adverse effects
- Rats
- Rats, Wistar
- Single-Blind Method
- Systemic Inflammatory Response Syndrome -- drug therapy
- Zymosan -- adverse effects
- beta-Glucans -- adverse effects
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.